智能药物输送的双响应纳米粒子:一个基于NIR光敏感和氧反应的PEG-PCL系统
Nancy Ferrentino1, Taha Behroozi Kohlan2, Shokoufeh Mehrtashfar2,3
1Dipartimento di Scienze e Tecnologie, Università del Sannio, via de Sanctis snc, 82100 Benevento, Italy.
Biomacromolecules
|November 11, 2024
概括
本研究介绍了一种使用聚合物纳米粒子的双响应药物递送系统. 这些纳米粒子在接触到特定的光或生物刺激时释放药物,为向治疗提供了一种智能方法.
科学领域:
- 材料科学 材料科学 材料科学
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
背景情况:
- 响应刺激的聚合物纳米粒子 (NP) 是先进的药物递送系统 (DDS).
- 它们可以控制由外部或内部刺激触发的药物释放.
- 开发双响应系统可以提高治疗精度.
研究的目的:
- 为了合成和表征一种用于药物输送的新型双响应的triblock共聚合物.
- 为了研究尼罗河红色 (NR) 载荷NP的刺激触发释放.
- 评估开发的NP的生物相容性和细胞吸收.
主要方法:
- 合成聚乙烯基醇和聚乙烯基醇 (PCL-SS-PEG-SS-PCL) 的共聚物.
- 使用NMR,SEC和FTIR进行表征.
- 通过DLS和FESEM准备和分析尼罗河红色载荷NP.
- 使用光光谱学在UV/NIR光和GSH刺激下监测药物释放.
- 通过光显微镜评估AlamarBlue测定和细胞吸收的细胞活力.
主要成果:
- 双反应性共聚物的成功合成.
- 尼罗河红色载荷NP在UV/NIR光和GSH暴露后显示有控制的释放.
- 同时的刺激导致药物释放加速.
- 负载NR的NP表现出良好的细胞活力和有效的细胞吸收在人类皮肤纤维细胞.
结论:
- 合成的PCL-SS-PEG-SS-PCL共聚合物形成了有效的双响应NP用于药物输送.
- 该系统显示了有针对性和受控释放应用的潜力.
- 这些NP是生物相容的,并且很容易被细胞内化,这表明智能治疗策略的前景.
相关概念视频
Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.


